Xlera8

AKTIONÆRADVARSEL: Pomerantz Advokatfirma undersøger krav på vegne af investorer i Aquestive Therapeutics, Inc. – AQST

NEW YORK, Marts 24, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Aquestive Therapeutics, Inc. (“Aquestive” or the “Company”) (NASDAQ: AQST). Such investors are advised to contact Robert S. Willoughby at  [e-mail beskyttet] eller 888-476-6529, udvid. 7980.

The investigation concerns whether Aquestive and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Klik her for at få oplysninger om deltagelse i klasseaktionen] 

On September 25, 2020, Aquestive announced receipt of a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration (“FDA”) “regarding the New Drug Application (NDA) for Libervant™ (diazepam) Buccal Film for management of seizure clusters.” Aquestive advised investors that “[i]n the CRL, the FDA cited that, in a study submitted by the Company with the NDA, certain weight groups showed a lower drug exposure level than desired. The Company intends to provide to the FDA additional information on PK modeling to demonstrate that dose adjustments will obtain the desired exposure levels.” 

On this news, Aquestive’s stock price fell $2.64 pr. aktie, eller 34.69%, til at lukke ved $4.97 pr. aktie den September 28, 2020.

Pomerantz-firmaet med kontorer i New York, Chicago, Los Angelesog Paris er anerkendt som en af ​​de førende virksomheder inden for områderne corporate, securities og antitrust class retstvister. Grundlagt af den sene Abraham L. PomerantzPomerantz -firmaet, der er kendt som dekan for gruppeaktioner, var banebrydende inden for værdipapirklasseaktioner. I dag, mere end 80 år senere, fortsætter Pomerantz -firmaet i den tradition, han etablerede, og kæmper for ofrenes rettigheder for værdipapirbedrageri, overtrædelser af fortrolige pligter og virksomhedsforseelser. Firmaet har tilbagebetalt adskillige tildelinger på flere millioner dollars på vegne af klassemedlemmer. Se www.pomerantzlaw.com.

KONTAKT:
Robert S. Willoughby
Pomerantz LLP
[e-mail beskyttet] 
888-476-6529 ext. 7980

KILDE Pomerantz LLP

Relaterede links

www.pomerantzlaw.com

Møntsmart. Bedste Bitcoin-Börse i Europa
Source: https://www.prnewswire.com:443/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-aquestive-therapeutics-inc—aqst-301254485.html

Chat med os

Hej! Hvordan kan jeg hjælpe dig?